Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,370 | -7,790 | -3,670 | -25,190 | -18,610 |
| Depreciation Amortization | 1,850 | 1,120 | 810 | 3,480 | 2,360 |
| Other Working Capital | -5,470 | -2,940 | -2,820 | 1,950 | -10 |
| Other Operating Activity | 870 | -1,920 | 130 | 1,180 | 990 |
| Operating Cash Flow | $-15,120 | $-11,530 | $-5,550 | $-18,580 | $-15,270 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | 0 | -30 | -30 |
| Other Investing Activity | -13,940 | -5,000 | 0 | -990 | -1,010 |
| Investing Cash Flow | $-13,940 | $-5,000 | $0 | $-1,020 | $-1,040 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 77,660 | 75,980 | 76,150 | -1,610 | -1,340 |
| Financing Cash Flow | $77,660 | $75,980 | $76,150 | $-1,610 | $-1,340 |
| Beginning Cash Position | 41,020 | 41,020 | 41,020 | 62,240 | 62,240 |
| End Cash Position | 89,610 | 100,470 | 111,620 | 41,020 | 44,570 |
| Net Cash Flow | $48,590 | $59,450 | $70,600 | $-21,220 | $-17,660 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,120 | -11,530 | -5,550 | -18,580 | -15,270 |
| Free Cash Flow | -15,120 | -11,530 | -5,550 | -18,580 | -15,270 |